Cargando…
A 14-day pulse of PLX5622 modifies α-synucleinopathy in preformed fibril-infused aged mice of both sexes
Reactive microglia are observed with aging and in Lewy body disorders, including within the olfactory bulb of men with Parkinson’s disease. However, the functional impact of microglia in these disorders is still debated. Resetting these reactive cells by a brief dietary pulse of the colony-stimulati...
Autores principales: | Bhatia, Tarun N., Jamenis, Anuj S., Abbas, Muslim, Clark, Rachel N., Miner, Kristin M., Chandwani, Manisha N., Kim, Roxanne E., Hilinski, William, O’Donnell, Lauren A., Luk, Kelvin C., Shi, Yejie, Hu, Xiaoming, Chen, Jun, Brodsky, Jeffrey L., Leak, Rehana K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528721/ https://www.ncbi.nlm.nih.gov/pubmed/37315905 http://dx.doi.org/10.1016/j.nbd.2023.106196 |
Ejemplares similares
-
Putting PLX5622 into perspective: microglia in central nervous system viral infection
por: Spiteri, Alanna G., et al.
Publicado: (2022) -
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
por: Mein, Nils, et al.
Publicado: (2023) -
Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination
por: Sharon, Aviv, et al.
Publicado: (2022) -
CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice
por: Ali, Seemaab, et al.
Publicado: (2020) -
PLX5622 Reduces Disease Severity in Lethal CNS Infection by Off-Target Inhibition of Peripheral Inflammatory Monocyte Production
por: Spiteri, Alanna G., et al.
Publicado: (2022)